Incidence and risk factors of venous and arterial thromboembolism events in lung cancer patients treated with immune checkpoint inhibitors
{{output}}
Background: Thromboembolism (TE), which comprises venous thromboembolism (VTE) and arterial thromboembolism (ATE), represents a significant cause of mortality in patients with lung cancer. It is also associated with considerable ... ...